Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
11.55
+0.40 (3.59%)
Apr 14, 2026, 4:00 PM EDT - Market closed
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $227.74 million as of April 14, 2026. Its market cap has decreased by -48.91% in one year.
Market Cap
227.74M
Enterprise Value
-42.79M
1-Year Change
-48.91%
Ranking
Category
Stock Price
$11.55
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has decreased from $385.32M to $227.74M, a decrease of -40.90%. That is a compound annual growth rate of -8.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 219.85M | -64.56% |
| Dec 31, 2025 | 620.29M | -3.27% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcturus Therapeutics Holdings | 240.46M |
| ALX Oncology Holdings | 230.31M |
| Voyager Therapeutics | 228.86M |
| MediWound | 226.84M |
| Context Therapeutics | 226.02M |
| Nuvectis Pharma | 224.12M |
| MacroGenics | 220.55M |
| Jyong Biotech | 214.55M |